Atlas Trials

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of DA-2803 in Healthy Subjects

Clinical trial NCT04906109 · COMPLETED

Trial details

NCT number
NCT04906109
Sponsor
Dong-A ST Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis B
Start date
2021-07-12
Primary completion
2021-10-05
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.